These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

335 related items for PubMed ID: 15595991

  • 1. Clinical benefits of early triptan therapy for migraine.
    Láinez M.
    Cephalalgia; 2004; 24 Suppl 2():24-30. PubMed ID: 15595991
    [Abstract] [Full Text] [Related]

  • 2. Clinical profile and practice experience of almotriptan.
    Gendolla A.
    Cephalalgia; 2004; 24 Suppl 2():16-23. PubMed ID: 15595990
    [Abstract] [Full Text] [Related]

  • 3. What do patients want from acute migraine treatment?
    Gallagher R.
    Cephalalgia; 2004; 24 Suppl 2():8-15. PubMed ID: 15595989
    [Abstract] [Full Text] [Related]

  • 4. The 'Act when Mild' (AwM) study: a step forward in our understanding of early treatment in acute migraine.
    Goadsby PJ.
    Cephalalgia; 2008 Sep; 28 Suppl 2():36-41. PubMed ID: 18715331
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Almotriptan for the treatment of acute migraine: a review of early intervention trials.
    Antonaci F, De Cillis I, Cuzzoni MG, Allena M.
    Expert Rev Neurother; 2010 Mar; 10(3):351-64. PubMed ID: 20187858
    [Abstract] [Full Text] [Related]

  • 10. Early triptan intervention in migraine: an overview.
    Moschiano F, D'Amico D, Allais G, Rigamonti A, Melzi P, Schieroni F, Bussone G.
    Neurol Sci; 2005 May; 26 Suppl 2():s108-10. PubMed ID: 15926006
    [Abstract] [Full Text] [Related]

  • 11. Almotriptan in triptan-naïve patients: new evidence of benefits.
    Pascual J.
    Cephalalgia; 2008 Sep; 28 Suppl 2():14-20. PubMed ID: 18715328
    [Abstract] [Full Text] [Related]

  • 12. Effect of pain intensity and time to administration on responsiveness to almotriptan: results from AXERT 12.5 mg Time Versus Intensity Migraine Study (AIMS).
    Freitag FG, Finlayson G, Rapoport AM, Elkind AH, Diamond ML, Unger JR, Fisher AC, Armstrong RB, Hulihan JF, Greenberg SJ, AIMS Investigators.
    Headache; 2007 Apr; 47(4):519-30. PubMed ID: 17445101
    [Abstract] [Full Text] [Related]

  • 13. Early intervention with almotriptan: results of the AEGIS trial (AXERT Early Migraine Intervention Study).
    Mathew NT, Finlayson G, Smith TR, Cady RK, Adelman J, Mao L, Wright P, Greenberg SJ, AEGIS Investigator Study Group.
    Headache; 2007 Feb; 47(2):189-98. PubMed ID: 17300358
    [Abstract] [Full Text] [Related]

  • 14. Almotriptan: a review of pharmacology, clinical efficacy, and tolerability.
    Von S.
    Am J Manag Care; 2002 Feb; 8(3 Suppl):S74-9. PubMed ID: 11859907
    [Abstract] [Full Text] [Related]

  • 15. Almotriptan: meeting today's needs in acute migraine treatment.
    Láinez MJ.
    Expert Rev Neurother; 2007 Dec; 7(12):1659-73. PubMed ID: 18052762
    [Abstract] [Full Text] [Related]

  • 16. Consistent efficacy, tolerability, and high levels of satisfaction with almotriptan 12.5 mg when used to treat multiple migraine attacks in routine clinical practice.
    Diener HC.
    Headache; 2005 Jun; 45(6):624-31. PubMed ID: 15953293
    [Abstract] [Full Text] [Related]

  • 17. Almotriptan in migraine patients who respond poorly to oral sumatriptan: a double-blind, randomized trial.
    Diener HC, Gendolla A, Gebert I, Beneke M.
    Headache; 2005 Jun; 45(7):874-82. PubMed ID: 15985104
    [Abstract] [Full Text] [Related]

  • 18. Priorities for triptan treatment attributes and the implications for selecting an oral triptan for acute migraine: a study of US primary care physicians (the TRIPSTAR Project).
    Cutrer FM, Goadsby PJ, Ferrari MD, Lipton RB, Dodick DW, McCrory D, Williams P.
    Clin Ther; 2004 Sep; 26(9):1533-45. PubMed ID: 15531016
    [Abstract] [Full Text] [Related]

  • 19. Almotriptan and zolmitriptan in the acute treatment of migraine.
    Goadsby PJ, Massiou H, Pascual J, Diener HC, Dahlöf CG, Mateos V, Dowson AJ, Raets I, Cunha L, Färkkilä M, Manzoni GC.
    Acta Neurol Scand; 2007 Jan; 115(1):34-40. PubMed ID: 17156263
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.